Tumoral Calcinosis, Hyperphosphatemic, Familial, 1 (HFTC1)

Alias:

Hyperostosis-Hyperphosphatemia Syndrome

Familial Hyperphosphatemic Tumoral Calcinosis/hyperphosphatemic Hyperostosis Syndrome

Hyperphosphatemic Familial Tumoral Calcinosis

Hftc

Cortical Hyperostosis with Hyperphosphatemia

Primary Hyperphosphatemic Tumoral Calcinosis

Hyperostosis with Hyperphosphatemia

Lipocalcinogranulomatosis

Morbus Teutschlaender

Phptc

Hhs

Tumoral Calcinosis, Hyperphosphatemic, Familial

Hyperphosphatemia Hyperostosis Syndrome

Hyperphosphatemia Tumoral Calcinosis

Hypercalcemic Tumoral Calcinosis

Hyperphosphatemia Hyperostosis

Hftc1

Familial Tumoral Calcinosis/hyperostosis-Hyperphosphatemia Syndrome

Familial Tumoral Calcinosis with Hyperphosphatemia

Calcinosis, Tumoral, Hyperphosphatemic, Familial

Tumoral Calcinosis, Primary Hyperphosphatemic

Tumoral Calcinosis Primary Hyperphosphatemic

Calcinosis, Tumoral, with Hyperphosphatemia

Tumoral Calcinosis with Hyperphosphatemia

Teutschlaender Disease, Familial

Familial Teutschlaender Disease

Teutschlaender Disease

Tumoral Calcinosis

Ftc/hhs

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Tumoral Calcinosis, Hyperphosphatemic, Familial, 1, also known as hyperostosis-hyperphosphatemia syndrome, is related to hyperostosis and dental pulp calcification. An important gene associated with Tumoral Calcinosis, Hyperphosphatemic, Familial, 1 is GALNT3 (Polypeptide N-Acetylgalactosaminyltransferase 3), and among its related pathways/superpathways are Infectious disease and Signaling by Receptor Tyrosine Kinases. The drugs Salmon calcitonin and Calcitonin gene-related peptide have been mentioned in the context of this disorder. Affiliated tissues include bone and skin, and related phenotypes are hyperphosphatemia and high serum calcitriol

Related ID：

MALACARDS：TMR018

OMIM：211900

MESH：D002114